July 18, 2016
(Medical Xpress) – EU scientists are researching an innovative treatment that grafts dopamine cells into the brains of patients with Parkinson’s Disease that could substantially improve their lives. TRANSEURO, an EU research project, has set itself the ambitious aim to help improve the quality of life of patients diagnosed with Parkinson’s Disease. To do this, it is studying patients with a relatively young onset of the disease and their tolerance to an innovative treatment which involves transplanting fetal ventral mesencephalic tissue.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.